Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Published in: Intensive Care Medicine 4/2020

01-04-2020 | Shock | Letter

Capillary refill time status could identify different clinical phenotypes among septic shock patients fulfilling Sepsis-3 criteria: a post hoc analysis of ANDROMEDA-SHOCK trial

Authors: Glenn Hernández, Eduardo Kattan, Gustavo Ospina-Tascón, Jan Bakker, Ricardo Castro, The ANDROMEDA-SHOCK Study Investigators and the Latin America Intensive Care Network (LIVEN)

Published in: Intensive Care Medicine | Issue 4/2020

Login to get access

Excerpt

Dear Editor, …
Appendix
Available only for authorised users
Literature
1.
Singer M, Deustchman C, Warren Seymour C, Shankar-Hari M, Annane D, Bauer M et al (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:801–810PubMedPubMedCentral
2.
Alegría L, Vera M, Dreyse J et al (2017) A hypoperfusion context may aid to interpret hyperlactatemia in sepsis-3 septic shock patients: a proof-of-concept study. Ann Intensive Care 7:29CrossRef
3.
Hernandez G, Ospina-Tascon G, Petri Damiani L et al (2019) Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock. The ANDROMEDA-SHOCK Randomized Clinical Trial. JAMA 321:654–664CrossRef
4.
5.
Seymour CW, Kennedy JN, Wang S et al (2019) Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA 321:2003–2017CrossRef
Metadata
Title
Capillary refill time status could identify different clinical phenotypes among septic shock patients fulfilling Sepsis-3 criteria: a post hoc analysis of ANDROMEDA-SHOCK trial
Authors
Glenn Hernández
Eduardo Kattan
Gustavo Ospina-Tascón
Jan Bakker
Ricardo Castro
The ANDROMEDA-SHOCK Study Investigators and the Latin America Intensive Care Network (LIVEN)
Publication date
01-04-2020
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 4/2020
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-020-05960-4

Other articles of this Issue 4/2020

Intensive Care Medicine 4/2020 Go to the issue

Editorial

The wicked path of causal inference in observational studies

Understanding the Disease

Why we need safer anticoagulant strategies for patients on short-term percutaneous mechanical circulatory support

Systematic Review

Rate and risk factors for rehospitalisation in sepsis survivors: systematic review and meta-analysis

Correspondence

Leptospirosis: different presentation and mortality in tropical and non-tropical areas

Letter

Prehospital identification of community sepsis using biomarkers of host response

Understanding the Disease

Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin